Nephrogenic Systemic Fibrosis (NSF) is a rare, but serious tissue abnormality that can become extremely painful.  NSF was first documented in 1997 and it remains unclear what first caused a discovery of this disfiguring and potentially fatal disorder.  However, recent studies have directly linked gadodiamide to NSF.  Gadodiamide is a gadolinium-based contrast agent used in MRI (magnetic resonance imaging). 

Gadolinium injury claims are on the rise due to these serious and potentially life-threatening side effects.  It is important for any gadolinium product defect victim to understand that not all MRI scans are done with contrast agents.  In fact, most MRI are conducted without contrast.  Patients will know the difference, as they are physically injected with the gadolinium contrast agent prior to the MRI scan. 

Studies show that the chances of developing some symptoms of NSF following a gadolinium MRI scan are around 25%.  This is especially concerning for all consumers who have been injected with gadolinium in preparation for a bone scan or MRI contrast scan.  Consumers should contact a gadolinium injury lawyer immediately to examine whether they have a viable gadolinium injury claim against General Electric or Bayer Healthcare.  Don't be victimized twice.  Protect your rights and contact a drug recall injury lawyer today for an immediate attorney consultation to discuss your right to compensation.